Litcius/Paper detail

Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial

Jean-Marc Classe, Pierre Méeus, Delphine Hudry, Romuald Wernert, François Quénet, Frédéric Marchal, Gilles Houvenaeghel, Anne‐Sophie Bats, Fabrice Lécuru, Gwénaël Ferron, Cécile Brigand, Dominique Berton-Rigaud, Laurence Gladieff, Florence Joly, Isabelle Ray‐Coquard, Sylvaine Durand‐Fontanier, Gabriel Liberale, Marc Pocard, C Georgeac, Sébastien Gouy, Jean‐Marc Guilloit, Frédéric Guyon, Cristina Costan, J Rousselet, Lara De Guerké, Naoual Bakrin, Emilie Brument, E. Martin, Bernard Asselain, L. Campion, Olivier Gléhen

2024The Lancet Oncology63 citationsDOIOpen Access PDF

Topics & Concepts

Hyperthermic intraperitoneal chemotherapyMedicineOvarian cancerCytoreductive surgeryChemotherapyIntraperitoneal chemotherapyOncologyInternal medicineSurgeryCancerIntraperitoneal and Appendiceal MalignanciesOvarian cancer diagnosis and treatmentNanoplatforms for cancer theranostics